Symrise Ag · XETR:SY1
Symrise — Symrise Ag Ord — Q2 2026 Earnings Presentation
29 slides from Symrise's earnings presentation, Jul 30, 2026
Slide 1: Financial Results H1/Q2 2026
Financial Results H1/Q2 2026 — Dr Jean-Yves Parisot (CEO), Olaf Klinger (CFO) July 30, 2026
Slide 2: Agenda
Agenda Overview — 1 2 3 4 Highlights Financials Strategy 2026 H1/Q2 2026 H1/Q2 2026 Update Outlook Dr Jean-Yves Parisot, CEO Olaf Klinger, CFO 2
Slide 3: Highlights H1/Q2 2026
01 Highlights H1/Q2 2026 3
Slide 4: Highlights H1 2026
Highlights H1 2026 HIGHLIGHTS H1/Q2 2026 — Delivered sequential organic sales growth 1 improvement driven by market success in North America and Asia Pacific Sales €2,539m +2.0% -0.6% year-on-year Organic sales growth Progressing on strategy and sharpening 2 portfolio through planned acquisition of
Slide 5: Q2 2026: Sales Performance
Q2 2026: Sales Performance HIGHLIGHTS H1/Q2 2026 Market-leading OSG in Food & Beverage, strong performance in Consumer Fragrance — Group Taste, Nutrition & Health Scent & Care in €m in €m in €m +4.3% 1,237 +4.5% -0.1% 0.0% 1,290 -1 0 +4.4% 55 +4.9% -0.2% -0.3% 748 782 +4.1% 36 -1 -2 488 +3.8% 0.0% +
Slide 6: Q2 2026 Sales by Region
Q2 2026 Sales by Region HIGHLIGHTS H1/Q2 2026 Strong momentum in North America and Asia Pacific supports resilient performance — amid uneven regional market conditions Organic sales growth by region Sales by region % of global sales 22% 25% North America +9.6% Asia €1,290m Q2 Pacific EAME +12.3% 13%
Slide 7: Q2 Execution Highlights
Q2 Execution Highlights HIGHLIGHTS H1/Q2 2026 Continuing to drive growth while earning recognition for highest standards — GROUP • Broke ground on the second phase of construction for logistics center in Holzminden (Germany) • Received CDP’s top “A” rating for sustainable supplier engagement and sco
Slide 8: Financials H1/Q2 2026
02 Financials H1/Q2 2026 8
Slide 9: H1 2026: Group Profitability
H1 2026: Group Profitability FINANCIALS H1/Q2 2026 Strong profitability supported by solid underlying business performance — Gross Profit • Gross profit of €1,049m and gross margin Group of 41.3% remained broadly stable Adj. EBITDA in €m & Adj. EBITDA margin in %1 (H1 2025: 41.4%) despite a challeng
Slide 10: H1 2026: Segment Profitability
H1 2026: Segment Profitability FINANCIALS H1/Q2 2026 Solid underlying segment performance despite temporary margin headwinds — Taste, Nutrition & Health Scent & Care Adj. EBITDA in €m & Adj. EBITDA margin in %1 Adj. EBITDA in €m & Adj. EBITDA margin in %1 24.4% 24.5% 18.6% 17.7% +0.6% -6.7% 372 375
Slide 11: H1 2026: Business Free Cash Flow (BFCF)
H1 2026: Business Free Cash Flow (BFCF) FINANCIALS H1/Q2 2026 Strong performance demonstrates resilience and disciplined cash management — H1 Adj. BFCF (in €m) and Margin1 • Strong cash generation 347 +47.3% YoY momentum continued in H1, 226 236 with Adjusted BFCF reaching 13.7% 13.7% +450 bps YoY o
Slide 12: H1 2026: Balance Sheet and Net Debt
H1 2026: Balance Sheet and Net Debt FINANCIALS H1/Q2 2026 Disciplined capital allocation while maintaining leverage within target — range Balance Sheet FY 2025 H1 2026 Cash and Cash Equivalents €1,010m €451m Equity Ratio 47.3% 49.2% 1 • Net debt1 increased to €2.3bn Net Debt €2,088m €2,303m Net Leve
Slide 13: Strategy & Transformation Update
03 Strategy & Transformation Update 13
Slide 14: Executing Our ONE Symrise Strategy and ONE SYM Transformation
Executing Our ONE Symrise Strategy and ONE SYM Transformation STRATEGY & TRANSFORMATION UPDATE ONE Symrise Strategy ONE SYM Transformation — PLANNED INNOVATE IN HEALTH, WELLBEING AND BEAUTY, PURPOSE FOR THE ENTIRE FAMILY’S EVERYDAY LIFE ACTIVE Phase 3: COMPLETED Drive WHERE PORTFOLIO: Phase 2: Momen
Slide 15: ONE Symrise in Action: Portfolio Spotlight
Portfolio ONE Symrise in Action: Portfolio Spotlight STRATEGY & TRANSFORMATION UPDATE Sharpening portfolio quality through disciplined capital allocation DIVEST BUY Focus and Simplify Strengthen and Grow ✔ Focus on higher-growth, innovation-led businesses with long-term strategic fit ✔ Deliver highe
Slide 16: Creating a Leading Position in Premium Naturals
Portfolio Fine Fragrance | Creating a Leading Position in Premium Naturals STRATEGY & TRANSFORMATION UPDATE Floral Concept’s premium Naturals capabilities, in combination with Maison Lautier’s heritage, will extend the success story of Naturals from flavors to fragrances Strong strategic fit Attract
Slide 17: Accelerating ONE SYM Transformation to Support Growth and Efficiency
Growth & Efficiency Accelerating ONE SYM Transformation to Support Growth and Efficiency STRATEGY & TRANSFORMATION UPDATE PLANNED ACTIVE / ACCELERATED Phase 3: Future Phase 2: Q2 2025 Activate & Deliver Drive Momentum & 5-7% Performance in a Structured Way Organic Sales Growth ambition by 2028 Drive
Slide 18: ONE SYM Transformation Acceleration: Providing Foundation for Long-term Profitable Growth
Growth & Efficiency ONE SYM Transformation Acceleration: Providing Foundation for STRATEGY & TRANSFORMATION UPDATE Long-term Profitable Growth through Strategic Reinvestments Phase 2: Activate & Start Delivering in a Structured Way Implement Measures Define Ambition and Validate and Prepare to Deliv
Slide 19: ONE SYM Transformation Acceleration: Growth
Growth ONE SYM Transformation Acceleration: STRATEGY & TRANSFORMATION UPDATE Increasing Growth and Enhancing Competitiveness Our priorities to achieve 5-7% Organic Sales Growth • Targeted growth investments High-Growth Markets • Align sales and product strategy in attractive markets • Enhance sales
Slide 20: ONE SYM Transformation Acceleration: Efficiency
Efficiency ONE SYM Transformation Acceleration: STRATEGY & TRANSFORMATION UPDATE Turning Savings and Strategic Reinvestments into Margin Improvements Our priorities to further accelerate efficiencies • Capture economies of scale Sourcing & Procurement • Centralized tendering for MRO, freight and log
Slide 21: 2026 Outlook
04 2026 Outlook 21
Slide 22: FY 2026 Outlook and Mid-Term Targets
FY 2026 Outlook and Mid-Term Targets 2026 OUTLOOK — 2026 Outlook Mid-term Targets (2025-2028) Organic 2%-4% 5%-7% (CAGR) Sales growth EBITDA margin 21.5%-22.5% (Adjusted) 21%-23% BFCF margin >14% (Adjusted) >14% Commentary • Current business momentum supports Q3 • Multi-year growth opportunities org
Slide 23: Our Continuing Commitment
Our Continuing Commitment Controlling the controllables while executing ONE Symrise Strategy and — accelerating multi-year ONE SYM Transformation 1 2 3 Enhance Drive durable, Increase competitiveness profitable growth shareholder value through the across all our through durable acceleration of the b
Slide 24: Symrise AG
Symrise AG — Financial calendar Contact 28 October 2026 Symrise AG Q3 Trading Statement 2026 Muehlenfeldstraße 1 37603 Holzminden, Germany René Weinberg Investor Relations rene.weinberg@symrise.com This document contains forward-looking statements, which are based on the current estimates and assump
Slide 25: Appendix
Appendix 25
Slide 26: H1 2026: Sales Performance
H1 2026: Sales Performance HIGHLIGHTS H1/Q2 2026 Market-leading OSG in Food & Beverage, strong performance in Fragrance — Group Taste, Nutrition & Health Scent & Care in €m in €m in €m -0.6% +2.0% -0.1% -2.4% 2,554 2,539 50 -3 -62 +0.2% +3.2% -0.2% -2.9% 1,527 1,530 -1.7 % -3 1,026 0.0 % 0.0 -1.7 %
Slide 27: Adjustment Details
Adjustment Details — 2025, H1: Adjustments were made for one-time effects of loss and impairment as well as consulting costs associated with the sale and discontinuation of businesses and strategic considerations in the context of portfolio optimization of the aqua business, costs associated with th
Slide 28: Glossary
Glossary — APAC Asia Pacific BFCF Business Free Cash Flow DD Double digit EAME Europe, Africa, Middle East FX Foreign exchange HSD High single digit LATAM Latin America LSD Low single digit LTM Last twelve months MSD Mid single digit NA North America OSG Organic sales growth 28
Slide 29: symrise
ry symrise always inspiring more